Chi-square analysis showed that METTL3 expression was significantly associated with tumor size and hepatitis B surface antigen (HBsAg) status, but not with gender, age, hepatitis C core antigen (HCVAg), or tumor-node-metastasis (TNM) stage (Table 1). Here, METTL3 is linked to neoplasm.